FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer
Status:
Terminated
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety of a shorter course of radiation
treatments combined with one year of androgen deprivation therapy. The study will test this
treatment in men with high risk prostate cancer who have significant other illnesses or
circumstances such that conventional long term radiotherapy and hormone therapy is not
recommended by their physician or desired by the patient.